Source: International Congress 2016 – Monitoring comorbidities



Rating:

Share or cite this content

Citations should be made in the following way:
José Eduardo Coutinho Costa (Coimbra, Portugal), José Eduardo Coutinho Costa, João Pedro Neiva Machado, Catarina Ferreira, Jorge Gama, Cidalia Rodrigues. The bronchiectasis severity index (BSI) and FACED score for assessment the severity of bronchiectasis. Eur Respir J 2016; 48: Suppl. 60, 4154

Member's Comments

No comment yet.

Related content which might interest you: The bronchiectasis severity index and FACED score for bronchiectasis Source: Eur Respir J 2016; 47: 382-384 Year: 2016 Bronchiectasis exacerbations risk prediction using severity scales BSI and FACED Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Rheumatoid arthritis and bronchiectasis: A multicentre study assessing pulmonary disease severity using the bronchiectasis severity index (BSI) Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Contribution of BSI and FACED scores in prediction of bronchiectasis mortality Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study Source: Eur Respir J 2016; 47: 482-489 Year: 2016 Modified pulmonary index score (MPIS) and indication of hospitalization for acute asthma exacerbation in children Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 A new severity score for community-acquired pneumonia: PARB score Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 The derivation of a new index of severity for COPD patients, the DOSE index: MRC dyspnea scale, airflow obstruction, smoking status and exacerbations Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007 Assessment of disease severity using imaging scores in pulmonary sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Evaluation of different domains of the Saint George‘s respiratory questionnaire (SGRQ) according to the severity levels of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Longitudinal performance of the bronchiectasis severity index (BSI) in patients on regular intravenous (IV) antibiotic therapy for bronchiectasis Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 The pneumonia severity index (PSI) do not underestimate the severity of community-acquired pneumonia (CAP) in young patients: results from the CAPO international study Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 Higher BODE Index in COPD patients correlated with higher number of comorbidities Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Dyspnoea, obstruction, smoking and exacerbation (DOSE) index and mortality in COPD Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011 The weight of radiological severity in patients with non-CF bronchiectasis Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007 A Comparison of three severity assessment scores: APACHI II SOFA and CURB 65 for predicting inpatient mortality in patients with acute exacerbation of COPD (AECOPD) Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015